Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Read
Follow The Money: US$500+ Million In New Psychedelics Financing Powering Massive Growth
Article By:
Jeff Nielson
Tuesday, January 26, 2021 7:44 PM EST
The huge dollar totals here are only half the story. Equally important is the progress in raising capital for individual companies.
In this article: , NM, HNLMF, LKYSF, MMED, HAVN, CMPS, RVVTF, MMEDF, MCURF, MYCOF, FTRPF, MYCO, HAVLF, CLXPF
E Psychedelic Drug Company Business Development Reflected In Higher Stock Prices YTD
Article By:
Lorimer Wilson
Saturday, January 16, 2021 10:31 PM EST
Below is the latest news and stock prices for each of 30 companies operating in the fledgling but burgeoning psychedelic bio-pharmaceutical drug sector from the beginning of 2021 to date.
Big Financings Powering Future Profits In Psychedelic Stocks
Article By:
Jeff Nielson
Friday, December 4, 2020 9:30 PM EST
$400 million in investment capital has flooded into psychedelic drug companies in just the last 10 weeks. Investors take note.
Why An ATAI IPO Is Driving MindMed Stock
Article By:
Jeff Nielson
Tuesday, November 24, 2020 10:47 AM EST
ATAI Life Sciences has announced its going public in Spring 2021. MindMed Inc has exploded on this news. Find out why the two events are connected.